The good news is “yes, you can stay on-budget!“. The “Plan A” is an analytical approach to cost-effective Risk Based Budgeting (RBB). Authors Igor Stefanov, CEO Synergy Research Group, and Artem Andrianov, CEO Cyntegrity, explain how understanding, quantifying and mitigating risks that may impact clinical outcomes can lead to an overall cost reduction of 2%. Read how RBB can help you keeping your clinical trial on-budget.
About the Author: Linda Bunschoten - Global Director of Marketing
Linda has over 20 years of experience uncovering pain points and strategizing with MedTech organisations in order to secure and retain more clients. Her chief thinking responsibilities include translating insight into strategy and ensure that all project activities meet our clients’ quality expectations.